Summary of Significant Changes to the NIHGPS for March 2026 Version
The revised NIH Grants Policy Statement (NIHGPS, rev. March 2026) represents an update to the April 2024 version and includes policies and requirements that have been published via Guide Notices in effect as of March 17, 2026. While the update does not introduce any new NIH material for the first time, it incorporates new and modified requirements, clarifies certain policies, and implements changes in statutes, regulations, and policies that have been implemented through appropriate legal and/or policy processes since the previous version of the NIHGPS dated April 2024. The March 2026 revision supersedes, in its entirety, the NIH Grants Policy Statement (April 2024) as a standard term and condition of the award.
Notable Policy Changes: Implements new policies and provides clarification of existing policies that were previously announced in the NIH Guide for Grants and Contacts since April 2024 and listed at Notice of NIH Policy Changes.
| Section |
TItle |
Comments |
| All sections | GPS throughout | Updated references to diversity, equity, and inclusion plans, gender and/or policies no longer in effect in line with updated NIH priorities. |
| All sections | GPS throughout | Changed references of "Facilities and Administration (F&A) Costs" to "Indirect Costs" in line with 2 CFR 200. |
| All sections | GPS throughout | Changed references of "non-Federal entity" to "recipients and subrecipients" in line with 2 CFR 200. |
| All sections | GPS throughout | Removed references to publication of Notices of Funding Opportunities in the NIH Guide to Grants and Contracts, per NOT-OD-25-143. |
| All sections | GPS throughout | Removed references to Commons Quick Queries. See NOT-OD-24-111. |
| All sections | GPS throughout | NIH no longer recognizes foreign subawards. See NOT-OD-25-104 |
| All sections | GPS throughout | Edited to reflect that NIH funds will not be permitted for research using HFT from elective abortions in line with NOT-OD-26-028. |
| 1.2 | Definition of terms | Updated definitions section through to align definitions with 2 CFR 200.1. |
| 1.2 | Definition of terms | Added definition of Human biospecimens. See NOT-OD-25-160. |
| 1.2 | Definition of terms | Updated to clarify that for PD/PIs and senior/key personnel, monetary donations given with an expectation must be disclosed. |
| 1.2 | Definition of terms | Added definition of U.S. Person. See NOT-OD-25-160 |
| 2.3.4 | Types of applications | Clarified definition of a Revision (Type 3) award and added description of an Administrative Supplement (Type 3) award. |
| 2.3.7.2 | Requirements for Submitting Unsolicited Applications Requesting $500,000 or More in Direct Costs | Section deleted as a result of removing the requirement as outlined within: NOT-OD-26-019. |
| 2.3.7.7 | SAM Registration and Unique Entity Identifier (UEI) Requirements | Clarified that applicant organizations must maintain a “current and active” registration with SAM.gov and added a requirement that applicant organizations and recipients review and update information in SAM.gov annually as required under 2 CFR 25.200(b). |
| 2.3.7.12 | NIH Application Limits | Added new section outlining calendar year limits for applications from an individual Principal Investigator/ Program Director or Multiple Principal Investigator in line with NOT-OD-25-132. |
| 2.3.7.13 | Appropriate Use of Artificial Intelligence (AI) | Added new section outlining the appropriate use of Artificial Intelligence in line with NOT-OD-25-132. |
| 2.4.1 | Initial Review | Edited to reflect updates related to the Simplified Peer Review Framework and the centralization of peer review within the Center for Scientific Review. See NOT-OD-25-135. |
| 2.5.1 | Just-in-Time Procedure- Other Support | Added language requiring recipients to implement trainings on other support disclosure requirements for all faculty and researchers identified as Senior/Key Personnel in line with NOT-OD-25-133. |
| 4.1.3.1 | NIH Policy on Dissemination of NIH-Funded Clinical Trial Information | NIH is not changing the definition of clinical trials. However, NIH will no longer characterize Basic Experimental Studies in Humans (BESH) as clinical trials in line with NOT-OD-26-032. |
| 4.1.13 | Human Biospecimens Security Measures | New section added. See NOT-OD-25-160. |
| 4.1.16.8 | Inclusion of Women and Members of Racial and/or Ethnic Minority Groups in Clinical Research | Renamed section and revised language to align with the NIH Director’s Unified Strategy (see NOT-OD-25-131). |
| 4.1.25.4 | Procurement of Synthetic Nucleic Acids and Benchtop Nucleic Acid Synthesis Equipment | New section on requirements for the procurement of synthetic nucleic acids. See NOT-OD-25-012. |
| 4.1.27.2 | Institutional Biosafety Committee (IBC) | Added requirement to post IBC minutes on a public-facing institutional website. See NOT-OD-25-082. |
| 4.1.36 | Mandatory Disclosures | In line with 2 CFR 200.113, added requirement for subrecipients to disclose to the pass-through entity when it has credible evidence of a violation of Federal criminal law as described in this section. |
| 4.1.39 | Whisteblower Protections | Added new section outlining whistleblower protections as described in 2 CFR 200.117. |
| 4.2.9 | Salary Cap/Salary Limitation | Clarified that the salary rate limitation tied to Executive Level II of the Federal Executive pay scale applies to direct and indirect salaries. See NOT-OD-25-025. |
| 6.1 | NIH Payment Review Process | New section added to implement Executive Order 1422 through new payment process requiring a justification for requesting funds and additional review before payments are approved. |
| 7.4 | Reimbursement of Indirect Costs | Updated to reflect that under the Consolidated Appropriations Act for FY 2026, (P.L. 119-75, Division B, Title II, Sec. 224), the provisions relating to indirect costs in 45 CFR 75, including with respect to the approval of deviations from negotiated rates, apply to NIH awards. |
| 7.9.1 | Selected Items of Costs | Clarifies that costs associated with the disposition of animals acquired for research (including adoption or retirement programs) are allowable. See NOT-OD-25-163. |
| 7.9.1 | Selected Items of Costs | Non-federal entities expending less than $1,000,000 in Federal awards during its fiscal year are exempt from Federal audit requirements in line with 2 CFR 200.501(e). |
| 7.9.1 | Selected Items of Costs | Added closeout costs as an allowable cost in line with 2 CFR 200.472(b). |
| 8.1.2.6 | Change in Status, Including Absence of PD/PI and Other Senior/Key Personnel Named in the NoA | Updated section to implement changes required by Section 238 of PL 119-75 related to investigations into harassment, bullying, retaliation or hostile working conditions. |
| 8.1.3 | Requests for Prior Approval | SBIR and STTR recipients are required to seek prior approval when adding a new subaward to a project post award, where the arrangement was not originally a part of the peer reviewed and approved application, and a foreign risk assessment is required for the entity selected for the subaward when the prior approval request is submitted in eRA Commons. See NOT-OD-24-149 and NOT-OD-25-040. |
| 8.2.2 | NIH Public Access Policy | Updated requirements for published manuscripts to be made publicly available upon publication as described in NOT-OD-25-047 and NOT-OD-25-101. |
| 8.2.3.1 | Operational and Security Standards for ControlledAccess Repositories | New section on requirements related to controlled access repositories. See NOT-OD-25-159. |
| 8.2.3.3 | Genomic Data Sharing (GDS) Policy | Updated to align with requirements outlined in NOT-OD-24-157 and GDS webpage. |
| 8.4.1.8 | Research Securities | New section implements requirements in accordance with the CHIPS and Science Act of 2022 (P.L. 117-167) and National Security Presidential Memorandum-33 (NSPM-33). |
| 8.4.1.8.2 | Malign Foreign Talent Recruitment Program Prohibition | New section implements Malign Foreign Talent Recruitment Program prohibition in accordance with the CHIPS and Science Act of 2022 (P.L. 117-167). See NOT-OD-26-018. |
| 8.4.1.8.3 | Research Security Training | New section on Research Security Training requirements. See NOT-OD-26-017. |
| 8.4.3 | Audit | Non-federal entities expending less than $1,000,000 in Federal awards during its fiscal year are exempt from Federal audit requirements in line with 2 CFR 200.501(e). |
| 8.5.2 | Remedies for Noncompliance or Enforcement Actions: Suspension, Termination, and Withholding of Support | Updates made to align with 2 CFR 200.339 and 200.340. |
| 8.6 | Closeout | Clarifies timeline requirements and enforcement actions as described in NOT-OD-24-055. |
| 8.8 | Alignment with Program Goals and Agency Priorities | New section notifying recipients that NIH may terminate awards, to the extent authorized by law, if an award no longer effectuates the program goals or agency priorities. See NOT-OD-26-009. |
| 11.2.4.2 | Scored Review Criteria | Updated review criteria and related verbiage in line with NOT-OD-24-107. |
| 11.3.8.9 | Childcare Costs | Added new section confirming childcare costs are allowable for full-time predoctoral or postdoctoral NRSA trainees as described in NOT-OD-24-116 and NOT-OD-25-100. |
| 14.1 | General | Removed language regarding requirement for Letters of Intent for conference grants. See NOT-OD-26-040. |
| 14.10.1 | Allowable Costs | Updated to allow costs of providing dependent care resources for participants under conference grants in line with 2 CFR 200.432. |
| 15 | Consortium Agreements | Updated Chapter 15 throughout to state that NIH no longer recognizes foreign subawards. See NOT-OD-25104. |
| 15.1 | General | Added new requirement that a pass-through entity must confirm in SAM.gov that a potential subrecipient is not suspended, debarred, or otherwise excluded from receiving Federal funds in line with 2 CFR 200.332. |
| 15.1 | General | Added new requirement that subrecipients at all tiers must provide the pass-through entity with a certification statement whenever applying for funds, requesting payment, and submitting financial reports as outlined in 2 CFR Part 200.415(b). |
| 16 | Grants to Foreign Organizations, International Organizations, Domestic Grants with Foreign Components, and Collaborative International Research Awards | Title edited to reflect the new Collaborative International Research Project model. See NOT-OD-25-155. Chapter 16 has been updated throughout to note that NIH no longer recognizes foreign subawards. |
| 16.3 | Application Review | Revised review criteria for foreign or international organizations, or applications where Multiple PD/PIs are located at foreign organizations. See NOT-OD-24-107 and NOT-OD-25-155. |
| 16.7.4 | Audit | As described in NOT-OD-24-151 foreign recipients that expend $750,000 (cumulative amount) or more in Federal awards during their fiscal year are required to conduct either a single audit, performed in accordance with the requirements outlined in 2 CFR 200 Subpart F, or program-specific audit (as required by the terms and conditions of award). |
| 16.8 | Collaborative International Research Awards (PF5/RF2, UF5/UL2) | New section outlining requirements for collaborative international research awards. See NOT-OD-25-155. |
| 18.5.2 | Eligibility | Removed language to clarify that Small Business Concern eligibility for SBIR/STTR recipients must be maintained throughout the award in line with NOT-OD-22-143. |
| 18.5.2.3 | Minimum Level of Effort | Added language that allows small business concerns to subcontract a substantial portion of their Commercialization Readiness Program award to third parties through consultant and contractual arrangements. |
| 18.5.3.1 | Required Disclosures of Foreign Affiliations or Relationships to Foreign Countries | Added new section describing NIH’s due diligence program and associated requirements for SBIR/STTR applicants and recipients as described in NOT-OD-23-139, NOT-OD-24-029, and NOT-OD-25-102. |
| 18.5.5.6 | Prior Approval of New Subawards | Added new section requiring SBIR/STTR recipients to seek prior approval when adding a new subaward to a project post award, where the arrangement was not originally a part of the peer reviewed and approved application, and a foreign risk assessment for the entity selected for the subaward when the prior approval request is submitted in eRA Commons. See NOT-OD-24-149 and NOT-OD-25-040 |
| 18.5.5.7 | Monitoring Requirements for Relationships with Foreign Countries of Concern PostAward | Added new section describing responsibility of SBIR/STTR recipients to monitor relationships with foreign countries of concern post-award and provide updates to NIH in line with NOT-OD-23-139 and NOT-OD-24-029. |